Source: Medical Device Network

Mobidiag: Hologic concludes acquisition of Mobidiag for $808m

The post Hologic concludes acquisition of Mobidiag for $808m appeared first on Verdict Medical Devices.

Read full article »

Mobidiag's Competitors | Mobidiag's News | Mobidiag's Financials

Followers on Owler

195

Est. Annual Revenue

$25-100M

Est. Employees

100-250

CEO

Tuomas Tenkanen

CEO Approval Rating

90/100

Mobidiag is a Finland-based biotechnology company that manufactures and commercialization of vaccine products for the prevention and treatment of infectious diseases.